World Federation of Chinese Medicine Societies, Co-construction Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases by Henan & Education Ministry of P. R. China, Henan University of Chinese Medicine, The First Affiliated Hospital of Henan University of Chinese Medicine, Email:
Export PDF Favorites Scan Get Citation

The scientific establishment of traditional Chinese medicine (TCM) syndrome diagnostic criteria is the basic link to achieve standardization and normalization of TCM diagnosis and treatment. The ambiguous idea and method, incomplete key technology, and unformed development standard of the establishment of TCM syndrome diagnostic criteria restrict its development and application. Therefore, project team drafted the development guideline of TCM syndrome diagnostic criteria and modified it according to expert opinions, which was based on the technical system established previously. This guideline could be used as a reference for formulating diagnostic criteria. It is also applicable to clinical, teaching, and scientific research related to syndrome diagnostic criteria that professional personnel from various levels of TCM (integrated traditional Chinese and Western medicine) medical, teaching institutions, and research institutes participated.

Citation: World Federation of Chinese Medicine Societies, Co-construction Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases by Henan & Education Ministry of P. R. China, Henan University of Chinese Medicine, The First Affiliated Hospital of Henan University of Chinese Medicine. Guideline on establishing diagnostic criteria of Chinese medicine syndromes. Chinese Journal of Evidence-Based Medicine, 2023, 23(9): 993-998. doi: 10.7507/1672-2531.202303134 Copy

  • Previous Article

    Interpretation of consensus and recommendations of harms visualization in reports of randomized controlled trials
  • Next Article

    Interpretation of NLA scientific statement on statin intolerance: a new definition and key considerations for ASCVD risk reduction in the statin intolerant patients